SCMP Financial Facts

Income (loss) from operations: 13.27M
Contract and collaboration revenue: 2.38M
See Full Income Statement

Prepaid expenses and other current assets: 18.15M
Cash and cash equivalents: 128.47M
See Full Balance Sheet

Sucampo Pharmaceuticals (SCMP) Earnings

  |   Expand Research on SCMP
Next EPS Date 3/8/17 *Est. EPS Growth Rate +75.0% *Last Qtr.
Average EPS % Beat Rate +37.3% Revenue Growth Rate +72.8% *Last Qtr.
Average % Move 1-Wk after EPS +8.1% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/9/16 Q316 $0.28$0.26 +$0.02$57.9M$51.46M Details
8/3/16 Q216 $0.23$0.22 +$0.01$52M$48.61M Details
5/4/16 Q116 $0.21$0.19 +$0.02$47.2M$44.11M Details
3/8/16 Q415 $0.43$0.19 +$0.24$55.4M$42.72M Details
11/4/15 Q315 $0.16$0.18 -$0.02$33.5M$36.18M = Details
8/5/15 Q215 $0.21$0.15 +$0.06$34.9M$31.9M = Details
5/6/15 Q115 $0.14$0.12 +$0.02$29.5M$30.19M = Details
3/4/15 Q413 $0.21$0.18 +$0.03$37.8M$37.23M = Details